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β-1,2-mannosylation of Candida albicans glycoconjugates has been investigated through the identiﬁcation of
enzymes involved in the addition of β-1,2-oligomannosides (β-Mans) to phosphopeptidomannan and phospho-
lipomannan. β-1,2-oligomannosides are supposed to have virulence properties that they confer to these glyco-
conjugates. In a previous study, we showed that cell wall mannoproteins (CWMPs) harbor β-Mans in their
O-mannosides; therefore, we analyzed their biosynthesis and impact on virulence. In this study, we demonstrate
that O-mannans are heterogeneous and that α-mannosylated O-mannosides, which are biosynthesized by Mnt1
and Mnt2 α-1,2-mannosyltransferases, can be modiﬁed with β-Mans but only at the nonreducing end of α-1,2-
mannotriose. β-1,2-mannosylation of this O-mannotriose depends on growth conditions, and it involves
2 β-1,2-mannosyltransferases, Bmt1 and Bmt3. These Bmts are essential for β-1,2-mannosylation of CWMPs
and expression of β-Mans on germ tubes. A bmt1Δ mutant and a mutant expressing no β-Mans unexpectedly
disseminated more in BALB/c mice, whereas they had neither attenuated nor enhanced virulence in C57BL/6
mice. In galectin (Gal)3 knockout mice, the reference strain was more virulent than in C57BL/6 mice, suggesting
that the β-Mans innate receptor Gal3 is involved in C. albicans ﬁtness during infection.
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Candida albicans is a successful pathogen in immuno-
suppressed patients, leading to frequent nosocomial
infections with high mortality rate [1]. The fungal
cell wall and its components are the natural and dy-
namic interface with the host, forming a moving target
in terms of host recognition mechanisms [2]. Cell wall
glycans are immunologically active components,
which are present either as polysaccharides or glyco-
conjugates. Amongst its glycan diversity, C. albicans
expresses β-1,2-oligomannosides (β-Mans), which
are unusual as only evidenced in few nonmammalian
eukaryotes and prokaryotes [3]. β-Mans are present in
the N-glycan of the cell wall outer layer phosphopep-
tidomannan (PPM) [4].Within this molecule, they are
linked to a phosphomannose and at the nonreducing
end of α-1,2-oligomannosides (Figure 1A). β-Mans
are also associated to a cell wall glycolipid named
phospholipomannan (PLM) (Figure 1B) [5]. β-Mans
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biosynthesis involves β-1,2-mannosyltransferases (Bmts),
which have distinct substrate speciﬁcities and catalyze speciﬁc
steps of β-1,2-mannosylation [3].
β-Mans are involved in the interplay between C. albicans and
its host, for example, mediating adhesion of C. albicans to mac-
rophages and epithelial cells [6, 7], inducing cytokine production
[8], and generating protective antibodies against vaginal and dis-
seminated candidiasis [9, 10].However, very little is known about
their relative and respective functions inside the wall. Biological
activity of β-Mans depends on their carrier molecule. PPM and
PLM phosphomannosides both display β-Mans, but they have
distinct immune-modulatory properties [11–13].
In a previous study, we revealed the presence of β-Mans
epitopes on cell wall mannoproteins (CWMPs) O-mannan.
O-mannosylation is an essential glycosylation process for
protein modiﬁcation, but it is also important for C. albicans vir-
ulence [14]. Therefore, we determined which Bmts are respon-
sible for addition of β-Mans on O-mannosides and generated
the appropriate mutant to analyze (1) the contribution of N-
and O-mannans to the surface expression of β-Mans and (2)
the impact of these β-Mans on Candida virulence. We addition-
ally investigated the global role of β-Mans on Candida virulence
by generating a mutant expressing no β-Mans.
METHODS
Fungal Strains and Growth Conditions
All strains used are listed in Table 1. Yeast cells were grown in
YPD broth (1% yeast extract, 2% bactopeptone, 2% dextrose
[Difco]) and grown at 28°C or 37°C. Hyphae were obtained
after inoculation of RPMI 1640 medium (Invitrogen) with
yeast cells and incubation for 3 hours at 37°C. For animal exper-
iments, cells were grown in YPD at 28°C for 16 hours.
Lectin and Monoclonal Antibody
Biotinylated concanavalin A ([ConA] Sigma-Aldrich) detects
terminal α-D-mannosyl residues. Monoclonal antibodies
(mAbs) 5B2 (rat-mouse immunoglobulin [Ig] M) is speciﬁc
for β-Mans with a mannobiose as minimal epitope [15]. The
mAb 16B1 is a mouse IgG speciﬁc for hyphal wall protein 1
(Hwp1) [16].
Whole-Cell Protein Extraction and Western Blotting
Total extracts were obtained and analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis as previously de-
scribed [16, 17]. Membranes were probed with mAb 5B2 and
then an alkaline phosphatase-conjugated anti-rat IgM diluted
both 1:2000. Enzyme activity was detected with nitro blue
tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate substrate
(Promega). For lectin staining, membranes were incubated
with biotinylated ConA and then horseradish peroxidase-
labeled streptavidin (AbCam) diluted both 1:1000. Peroxidase
activity was detected with diamidobenzidine (Sigma-Aldrich).
Whole-Cell Hydrolysis and Fluorophore-Assisted-
Carbohydrate-Electrophoresis Analysis
Cells were boiled for 1 hour in 10 mM HCl. After cooling
and neutralization, the supernatants containing phosphoman-
nosides were harvested by centrifugation. Remaining cells
were washed and then incubated for 16 hours at room temper-
ature in 100 mM NaOH. After neutralization, O-mannosides
were harvested by centrifugation. Both supernatants were
ﬁltered through a 0.22 µm polyvinylidene ﬂuoride ﬁlter
(Millipore).
Hydrolysates were tagged with 0.15 M 8-amino-naphthalene-
1,3,6-trisulfonate ([ANTS] Sigma-Aldrich) as previously de-
scribed [18]. Electrophoresis of ANTS-labeled oligomannosides
Figure 1. Schematic representation of β-1,2-mannosyltransferase (Bmt)1–6 activities on Candida albicans cell-wall glycoconjugates. (A) β-1,2-oligoman-
nosides (β-Mans), expressed at the nonreducing end of α-1,2-Mans from N-mannan, are biosynthesized by Bmt1 and Bmt3. The Bmt2, Bmt3, and Bmt4
sequentially add β-mannose on phosphomannose linked to α-1,2-Mans of N-mannan. (B) Phospholipomannan β-1,2-mannosylation involves Bmt5 and
Bmt6, which transfer β-mannose on the inositol phosphate added to mannose-inositol-phosphoceramide. (C) This illustrates the detailed structure and
biosynthetic pathway of the 2 O-mannopentamers: the mannopentaose previously described (top panel) [14, 24] and the mannopentaose partly biosynthe-
sized by Bmt1 and Bmt3 as deduced from this study (bottom panel). The arrows indicate where the enzymes act and which β-mannose is added.
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was performed on 25%–30% acrylamide gels. Puriﬁed oligoman-
nosides from PPM were tagged with ANTS and used as carbohy-
drate standards. Gels were acquired with the Gel Doc 2000
apparatus (Bio-Rad).
Generation of Candida albicans Cells Expressing 6xHis Hwp1
Primers HWP1-1/HWP1-2 (Table 2) were designed to amplify
the promoter and the HWP1 open reading frame (orf19.1321;
http://www.candidagenome.org/) missing its last 75 nucleo-
tides. The ampliﬁed fragment was cloned in pYES2.1-TOPO
(Invitrogen) to fuse the gene to DNA sequence coding for
6xHis. A fragment of pYES2.1-TOPO-6xHIS-HWP1 was am-
pliﬁed using the primers HWP1-1/V5-His (Table 2) and cloned
in pCR2.1-TOPO. The sequence coding for 6xHis-Hwp1 was
released after digestion with NotI and SacI, gel puriﬁed, and
ligated into dephosphorylated CIp10. CIp10-6xHIS-HWP1
was linearized with NheI and integrated into HWP1 promot-
er of Candida cells. Correct integration of the plasmid was
conﬁrmed by Southern blot analysis with probes obtained
with primers probeFwd/probeRev (Table 2).
Production and Puriﬁcation of Secreted 6xHis Hwp1
Cells were grown for 3 hours at 37°C in hyphae-inducing me-
dium, M199 (Invitrogen). Supernatants were cooled and ﬁltered
through GF-F membranes (Millipore). 6xHis-Hwp1 was puri-
ﬁed using His-GraviTrap column (GE Healthcare Life Sciences)
following the manufacturer’s information. After dialysis using
PD-10 Desalting Columns (GE Healthcare Life Sciences),
6xHis-Hwp1 was analyzed by Western blotting.
Enzymatic Treatments
For α-mannosidase treatment, glycans were solubilized in
citrate buffer 50 mM, pH 4.6, and incubated for 8 hours at
room temperature with 0.7 units of α-mannosidase (Sigma-
Aldrich) from Canavalia ensiformis ( jack bean), speciﬁc for
α-1,2, α-1,3, and α-1,6 terminal mannose residues.
Table 1. Candida albicans Strains Used in This Study
Strain Parental Strain Genotype Reference
SC5314 Wild type [50]
BWP17 RM1000 arg4::hisG/arg4::hisG;his1::hisG/his1::hisG;ura3Δ::limm434/ura3Δ::
limm434,
[51]
BWP17+ CIp10 BWP17 BWP17 ::RPS10/rps1Δ::CIp10 This study
bmt1Δ+CIp10 BWP17 bmt1Δ::ARG4/bmt1Δ::HIS1, RPS10/rps1Δ::CIp10 [21]
bmt1Δ+CIp10-BMT1 bmt1Δ As bmt1Δ but RPS10/rps1Δ::CIp10-BMT1 [21]
bmt2Δ+CIp10 BWP17 bmt2Δ::ARG4/bmt2Δ::HIS1, RPS10/rps1Δ::CIp10 [21]
bmt3Δ+CIp10 BWP17 bmt3Δ::ARG4/bmt3Δ::HIS1, RPS10/rps1Δ::CIp10 [21]
bmt3Δ+CIp10-BMT3 Bmt3Δ As bmt3Δ but RPS10/rps1Δ::CIp10-BMT3 [21]
bmt4Δ+CIp10 BWP17 bmt4Δ::ARG4/bmt4Δ::HIS1, RPS10/rps1Δ::CIp10 [22]
bmt5Δ+CIp10 BWP17 bmt5Δ::ARG4/bmt5Δ::HIS1, RPS10/rps1Δ::CIp10 [22]
bmt6Δ+CIp10 BWP17 bmt6Δ::ARG4/bmt6Δ::HIS1, RPS10/rps1Δ::CIp10 [21]
bmt7Δ+CIp10 BWP17 bmt7Δ::ARG4/bmt7Δ::HIS1, RPS10/rps1Δ::CIp10 [21]
bmt8Δ+CIp10 BWP17 bmt8Δ::ARG4/bmt8Δ::HIS1, RPS10/rps1Δ::CIp10 [21]
bmt9Δ+CIp10 BWP17 bmt9Δ::ARG4/bmt9Δ::HIS1, RPS10/rps1Δ::CIp10 [21]
CAI-4 CAF2-1 ura3Δ::λimm434/ura3::λimm434 [52]
CAI-4 + CIp10 CAI-4 RPS10::rps10CIp10-URA3 This study
bmt1Δ CAI-4 As CAI-4 but bmt1Δ::dpl200/bmt1Δ::dpl200 This study
bmt1Δ+CIp10 bmt1Δ As bmt1Δ but bmt1Δ::dpl200/bmt1Δ::dpl200, RPS10/rps1Δ::CIp10 This study
bmt2Δ CAI-4 As CAI-4 but bmt2Δ::dpl200/bmt2Δ::dpl200 This study
bmt2Δ+CIp10 bmt2Δ As bmt2Δ but bmt2Δ::dpl200/bmt2Δ::dpl200, RPS10/rps1Δ::CIp10 This study
bmt2 Δ/bmt5Δ bmt2Δ As CAI-4 but bmt2Δ::dpl200/bmt2Δ::dpl200,bmt5Δ::dpl200/bmt5Δ::
dpl200
This study
bmt1Δ/bmt2 Δ/bmt5Δ+CIp10 bmt2 Δ/bmt5Δ As CAI-4 but bmt1Δ::dpl200/bmt1Δ::dpl200,bmt2Δ::dpl200/bmt2Δ::
dpl200, bmt5Δ::dpl200/bmt5Δ::dpl200, RPS10/rps1Δ::CIp10
This study
bmt1Δ+CIp10-BMT1 bmt1Δ As bmt1Δ but RPS10/rps1Δ::CIp10-BMT1 This study
NGY112 NGY111 As CAI-4 but mnt1-mnt2Δ::hisG/mnt1-mnt2Δ::hisG [14]
mnt1/mnt2Δ +CIp10 NGY112 As NGY112 but RPS10/rps10Δ::CIp10 [14]
CAI-4 + CIp10-6xHIS-HWP1 CAI-4 As CAI-4 but HWP1/hwp1Δ::CIp10-6xHIS-HWP1 This study
bmt1Δ+CIp10-6xHIS-HWP1 bmt1Δ As bmt1Δ but HWP1/hwp1Δ::CIp10-6xHIS-HWP1 This study
bmt2Δ+CIp10-6xHIS-HWP1 bmt2Δ As bmt2Δ but HWP1/hwp1Δ::CIp10-6xHIS-HWP1 This study
mnt1Δ/mnt2Δ+CIp10-6xHIS-HWP1 NGY112 As NGY112 but HWP1/hwp1Δ::CIp10-6xHIS-HWP1 This study
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For PNGase F treatment, proteins samples were suspended in
sodium phosphate 0.5 M, pH7.5 and incubated with peptide-
N-glycosidase F following the manufacturer’s recommendation
(Sigma-Aldrich).
Indirect Immunoﬂuorescence Assays
Hyphae were ﬁxed with formalin on reaction wells of micro-
scope slides (Thermo Scientiﬁc). Wells were blocked with phos-
phate-buffered saline containing 5% bovine serum albumin and
incubated for 1 hour at 37°C with mAb 5B2 or biotinylated
ConA diluted 1:500. Wells were washed and incubated with
the corresponding RPE-conjugated anti-Ig or ﬂuorescein isothio-
cyanate-conjugated streptavidin diluted 1:100, respectively.
Slides were examined under a Leica ﬂuorescence microscope.
Images were captured and analyzed with a Leica DC camera
and its software.
Gene Disruption
All mutants were generated in the CAI-4 background using the
mini ura-blaster method as previously described [19] using
primers BMTknockoutFwd/BMTknockoutRev (Table 2). Selec-
tionURA3marker was recycled with 5-ﬂuoroorotic acid. Disrup-
tion of both alleles for each gene was checked by Southern blot
with probes obtainedwith primers probeFwd/probeRev (Table 2).
A BMT1-reconstituted strain was constructed by cloning the
BMT1 region (−652 to +870) into CIp10 [20] and transforming
Ura–bmt1Δ strain with the resulting linearized CIp10-BMT1.
Linearized CIp10 was transformed into CAI-4 and the different
mutants. Single integration of these plasmids at the RPS1 locus in
the same allele was conﬁrmed by Southern blot analysis with
probes obtained with primers probeFwd/probeRev (Table 2).
Animal Experiments
All experiments, approved by the national ethics committee
(Reference no. 00374.03), were conducted following the French
Guide for the Care and Use of Laboratory Animals and the
Guidelines of the European Union.
For survival assays, cells were suspended in sterile physio-
logical saline. For each C. albicans strain, 5 female BALB/c
mice (8–10 weeks old) were given intravenous injections of
Table 2. Candida albicans Primers Used in This Study
Primers Sequences
BMT1 knockout Fwd CTAAAAAAGGTAAACGAACAATTATATTCCCAAATAATTTCAATCATGTTCATGATCATAAAGGTTCTTATATGATGA
AAGTTTTCCCAGTCACGACGTT
BMT1 knockout Rev TCTTTTTCAATTGTCCAAGATGAAATACCATTGGGGATAATTAAATTATAATGTTCACATAAACCTTTATCTAAATACC
ATGTGGAATTGTGAGCGGATA
BMT2 knockout Fwd CCTTCAGCCCTGTTTGGAAAAGTGTACAAAATAGGCACAAAGTTAAACTTTACACTACTTGCCCTTTGCTTACTTTT
GGCATTTTCCCAGTCACGACGTT
BMT2 knockout Rev TAAACCCATAATCATTCAATTCTAATAATTTCAGGTTTGGATCATCAAATAGTATTGACTTTAATAATCCTTTGATATG
ATGTGGAATTGTGAGCGGATA
BMT5 knockout Fwd GCAGTACCGATTTGCCCCAAAGTCAATATTCACATTTGTGTTTCTATGTTTTGTTGCAATAGTTGTCATAATATCCAC
ATCTTTTCCCAGTCACGACGTT
BMT5 knockout Rev CTGTTTGTTTGCAATAAATATTCAGATAATATCGACTTTAGTATTCCCTTCATGTGTATAATATCAACTGTAGAATCAGAT
GTGGAATTGTGAGCGGATA
probe BMT1 Fwd ATACAATCATTTAGTCATCAA
probe BMT1 Rev ATACTGGGATAGGGGCGATT
probe BMT2 Fwd GAGAAATGTGGCTGTGGTGA
probe BMT2 Rev TGTTTTTCGGGACCGTATGT
probe BMT5 Fwd GACTCGCCGTTATTGGACAT
probe BMT5 Rev ATTGGCACACCAAAATCCAT
probe URA3 Fwd GCCTCACCAGTAGCACAACGATTA
probe URA3 Rev GCATTCCAACCAGCATCTCTATACC
probe HWP1 Fwd CAACTCCAGCTACTACTCCA
probe HWP1 Rev GTCATTTCAGGAGCAGGAGC
probe RPS1 Fwd ATGGCTGTCGGTAAAAACAAG
probe RPS1 Rev AAAGCCAATAATGAACCCAAG
probe ACT1 Fwd ACCGAAGCTCCAATGAATCCA
probe ACT1 Rev GGATGGACCAGATTCGTCGTA
HWP1-1 CTCGAGTGTACGTAGCTTCTATAG
HWP1-2 TTCAAATGTAGAAATAGGAGC
V5-HIS CTCGAGTGCAGGGCCGCAGCTTGC
Abbreviations: Fwd, forward; Rev, reverse.
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2.105 colony-forming units (cfu) into the lateral tail vein. Mice
were monitored daily and humanely killed when they showed
signs of distress.
For determination of organ fungal burdens, cells were sus-
pended in sterile physiological saline. For each C. albicans
strain, 5 female BALB/c mice (8–10 weeks old) or 4 C57BL/6
or gal3−/− female mice (8–10 weeks old) were given intraperito-
neal injections of 5.107 cfu. Three days after injection, mice were
sacriﬁced and organs (spleen, kidneys and liver) were removed
aseptically, weighed, homogenized, and suspended in 5 mL
sterile water. Homogenates were plated on Sabouraud chloram-
phenicol agar and incubated for 24 hours at 37°C. Colony-
forming units were counted and reported to the organ’s weight.
The results shown are from 3 independent experiments. Sur-
vival data were analyzed by the Kaplan-Meier survival analysis.
Fungal burdens were analyzed by the Kruskal-Wallis test
followed by post hoc testing using the unpaired Mann–Whitney
U test. P values <.05 were considered signiﬁcant.
RESULTS
β-1,2-mannosyltransferases 1 and 3 Are Involved
in O-Mannosides β-1,2-Mannosylation
O-mannosides released from whole yeast cells were analyzed by
ﬂuorophore-assisted-carbohydrate-electrophoresis (FACE),
which separates oligosaccharides according to their degree of
polymerization, to the type of saccharide and to their glycosidic
linkage [18]. O-mannoside residues depended upon growth
temperature (Figure 2A). The O-mannopentaose migrated as
a doublet; the lower band was the main mannopentaose recov-
ered at 28°C. This residue and the mannotetraose were the only
O-mannosides resistant to α-mannosidase digestion, suggesting
that they may contain terminal β-Mans. To conﬁrm the pres-
ence of β-Mans in C. albicans O-mannan and to characterize
their biosynthesis, we applied the strategy used previously to
identify the 6 Bmts involved in the β-1,2-mannosylation of
PPM and PLM [21, 22] (Figure 1A and B). O-mannosides
from mutants lacking one of the 9 Bmts and their reference
strain, grown at 28°C, were analyzed by FACE. All bmtsΔ mu-
tants have similar O-mannosides than their reference strain, ex-
cept bmt1Δ and bmt3Δ mutants (Figure 2B). These mutants
display truncated O-mannosides with an accumulation of a
mannotriose and a mannotetraose, respectively. Both mutants
were lacking the lower O-mannopentaose band, whereas only
the bmt1Δ mutant did not express the O-mannotetraose. Nor-
mal O-mannosides were recovered when wild-type copies of
BMT1 and BMT3 were reintroduced into the corresponding
deletion strains (Figure 2B). The Bmt1 and Bmt3 certainly
added the ﬁrst and the second β-mannose onto the α-linked
O-mannotriose, respectively. These 2 Bmts used a substrate
Figure 2. Fluorophore-assisted-carbohydrate-electrophoresis (FACE) analysis of β-eliminated O-mannosides of Candida albicans reference strains and mu-
tants. (A) O-mannosides and phosphomannosides (P-mannosides) released by β-elimination and mild acid hydrolysis, respectively, from whole cells of strain
SC5314 grown at 28°C and 37°C were analyzed by FACE. Prior to the electrophoresis, α-mannosidase treatment was performed or not to remove terminal α-1,2,
α-1,3, and α-1,6 mannosyl residues. (B and C) O-mannosides from mutants lacking 1 of the 9 β-1,2-mannosyltransferases (Bmts), mutants lacking 2 enzymes
involved in cell wall O-mannosylation, Mnt1 and Mnt2, and their respective reference strain, BWP17 and CAI-4, respectively, were analyzed by FACE. All of the
strains were grown at 28°C before their O-mannosides were released by β-elimination treatment. All the mutants and their reference strains are Ura+ with CIp10
integrated in the same RPS1 allele. Different carbohydrate standards were used to evaluate the monomer number in the oligomannoside chains. Abbreviations:
M3, mannotriose; M4, mannotetraose; M5, mannopentaose; M6, mannohexaose; Mnt, α1,2-mannosyltransferase.
Candida β-Mannosylation and Virulence • OFID • 5
 at U
niversity of A
berdeen on O
ctober 23, 2015
http://ofid.oxfordjournals.org/
D
ow
nloaded from
 
biosynthesized by a protein mannosyltransferase isoform [23]
and by α1,2-mannosyltransferases (Mnt) 1 and/or 2 [14, 24]
and formed a heteropolymer (Figure 1C). As expected, FACE
analysis of O-mannosides from the double mnt1Δ/mnt2Δ
mutant revealed that, unlike the reference strain, they con-
tained neither a mannotetraose nor a mannopentaose (Fig-
ure 2C). Additional bands detected in mnt1Δ/mnt2Δ mutant
were certainly nonmannosyl products as previously reported
[14]. Reactivity to mAb 5B2 was reduced on CWMPs of
mnt1Δ/mnt2Δ mutant compared with the control strain,
whereas α-Mans levels were comparable between the 2 strains
(Figure 3A).
BMT1 Deletion Dramatically Affects Mannoproteins β-1,2-
Mannosylation
In contrast to PPM, β-Mans epitopes were not detected on
CWMPs from the bmt1Δ mutant, whereas CWMPs from the
other bmtΔmutants were β-1,2-mannosylated like the reference
strain (Figure 3B). Enhanced staining was obtained for the
bmt1Δ mutant with ConA compared with the other strains
(data not shown). This was likely to be due to the unmasking
of terminal α-mannosyl. These data reveal that CWMPs and
PPM are glycosylated in a different manner and that CWMPs
β-1,2-mannosylation is only initiated by Bmt1.
The β-1,2-mannosylation of a highly O-glycosylated CWMP,
the Hwp1 [25], was then studied. After replacement of the gly-
cosylphosphatidylinositol signal sequence with a 6xHis tag, re-
combinant Hwp1 was puriﬁed from culture supernatants of
CAI-4 and bmt1Δ strains by afﬁnity chromatography (Fig-
ure 3B). CAI-4 6xHis-Hwp1 was assessed by Western blot anal-
ysis using mAb 16B1 (Figure 3C). Protein staining showed that
6xHis-Hwp1 copuriﬁed with another protein of 75 kDa (data
not shown). Mass spectrometry analysis of this protein, which
was performed by the SICaPS platform of IMAGIF (www.
imagif.cnrs.fr), conﬁrmed that it was not a digestion product
of Hwp1 but was the hyphal cell wall protein Pra1 (pH Regu-
lated Antigen 1) [26]. The Pra1 is secreted by hyphal cells [27],
and thus it was not surprising to recover it from culture su-
pernatants. Furthermore, Pra1 is a zinc-binding protein [28],
with afﬁnity for other divalent cations, which may explain
why Pra1 copuriﬁed on the nickel column. Western blot anal-
ysis with mAb 5B2 showed that similar to Hwp1, Pra1 was
β-1,2-mannosylated; however, in contrast to Hwp1 [16], Pra1
had β-Mans epitopes in both O- and N-glycans (Figure 3C).
PNGase treatment of Pra1 resulted in a clear molecular weight
shift of this protein (Figure 3C) and a reduction in mAb 5B2
speciﬁcity.
Deletion of BMT1 deprived 6xHis-Hwp1 and Pra1 of their
β-Mans epitopes (Figure 3D). Similar results were obtained
with other anti-β-Mans antibodies (data not shown). Staining
with mAb 16B1 and ConA conﬁrmed that CAI-4 and bmt1Δ
expressed approximately equal amounts of proteins. Taken
together, these results suggest that, as for yeast CWMPs, initia-
tion of β-Mans expression on hyphal CWMPs is dependent on
Bmt1.
Figure 3. Mapping of β-1,2-oligomannosides epitopes on yeast and hy-
phal mannoproteins. (A and B) Western blots of whole-cell extracts from
different reference strains (CAI-4 and BWP17) and mutants (mnt1Δ/mnt2Δ
and bmtsΔ) grown at 28°C were stained with anti-β-1,2-oligomannosides
monoclonal antibody (mAb) 5B2 (A and B) and lectin concanavalin A
(ConA), speciﬁc for terminal α-mannosides (A). Phosphopeptidomannan
(PPM) and cell wall mannoproteins (CWMPs) are indicated. (C) Six His-
tagged recombinant Hwp1 (6xHis-Hwp1) was produced and secreted in
the culture supernatant by CAI-4 strain. Recombinant Hwp1 was puriﬁed
on nickel column together with a zinc-binding protein, Pra1. The 2 puriﬁed
hyphal mannoproteins were analyzed by Western blot with mAbs 16B1,
speciﬁc for Hwp1, and 5B2. Before separation by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis, the proteins were treated or not
with PNGase F. (D) The 6xHis-Hwp1 and Pra1 were expressed by CAI-4
strain and bmt1Δ mutant, puriﬁed on nickel column, and analyzed by West-
ern blot with mAbs 16B1 and 5B2 and lectin ConA. The 2 proteins are in-
dicated. All the mutants and their reference strains are Ura+ with CIp10
integrated in the same RPS1 allele.
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β-1,2-mannosyltransferase 1 Is Responsible for Surface
Expression of Hyphal β-1,2-oligomannosides
We showed previously that single BMT deletions have no effect
on β-Mans surface expression [21].Considering that β-Mans bi-
osynthesis is initiated by at least 3 Bmts, it is not surprising that
single deletion has no impact on surface expression of β-Mans.
Phosphopeptidomannan differs between yeast and hyphal cells
[29], with reduced amounts of β-Mans in PPM phosphoman-
nosides of hyphal cells. Therefore, we assessed whether deletion
of BMT1 would affect exposure of β-Mans on hyphae. Staining
of hyphal cells from selected strains with mAb 5B2 conﬁrmed
that, compared with CAI-4, the bmt1Δ mutant expressed
β-Mans on the mother cells but not on the lateral walls of
germ tubes (Figure 4). Expression of β-Mans in germ tubes
was recovered by the reintroduction of BMT1. In contrast,
bmt2Δ and bmt5Δ mutants expressed β-Mans at the surface
of both germ tubes and mother cells (data not shown). This im-
munoﬂuorescence conﬁrmed that, in contrast to mother cells,
germ tubes do not express β-Mans from N-glycan phospho-
mannosides and PLM (Figure 1A and B) on their surface.
The mnt1Δ/mnt2Δ mutant expressed, even if at a reduced
level, β-Mans on germ tubes (Figure 4), certainly at the nonre-
ducing ends of N-glycans (Figure 1A). These data show that the
glycosylation motifs on the cell wall surface vary between germ
tubes and mother cells. The β-Mans expressed on the germ tube
surface were therefore synthesized by Bmt1 and Bmt3 and cor-
respond to β-Mans from O-mannans and N-mannans at the
nonreducing end of α-1,2-Mans (Figure 1A and C).
BMT1 Deletion Affects Candida albicans Virulence
To investigate the possible involvement of β-Mans toO-manno-
sides virulence [14, 30], we analyzed the survival of the bmt1Δ
mutant in a murine model of invasive candidosis [31]. BALB/c
mice were chosen because they have been widely used to iden-
tify factors that contribute to C. albicans virulence. Mice re-
ceived a tail vein injection of either bmt1Δ mutant or its
reference strain for mortality studies. Deletion of BMT1 reduced
the survival of BALB/c mice, suggesting that the bmt1Δ mutant
displays hypervirulence (Figure 5A). Similar to β-Mans epitope
biosynthesis, wild-type virulence was partially recovered by
complementing the mutant with a single copy of BMT1. To an-
alyze the global role of β-Mans on virulence, we generated a
strain devoid of β-Mans. We deleted BMT2 and BMT5, coding
for Bmts that initiate the synthesis of β-Mans on PPM phospho-
mannosides and PLM (Figure 1A and B) in the bmt1Δ mutant
background. We conﬁrmed by Western blot analysis (data not
shown) and immunoﬂuorescence (Figure 4) that the bmt1Δ
bmt2Δ bmt5Δ mutant had no β-Man in its cell wall. This mu-
tant was as virulent as the bmt1Δ mutant (Figure 5A). To rule
out faster elimination of reference strain by blood cells or serum
components, we used a second murine model of invasive can-
didosis. Intraperitoneal injection of C. albicans has been used in
different studies as a systemic infection model to measure tissue
dissemination of the yeast [32–34]. Comparable results to the
survival assay were obtained when spleen, kidneys, and liver
fungal burdens were determined following BALB/c mice intra-
peritoneal infection (Figure 5B). Organs, particularly spleen
and liver, contained more fungal cells after mice challenge
with bmt1Δ mutant than reference strain (Figure 5B). All inde-
pendent experiments gave similar results, and even with the
strong heterogeneity of the mutant fungal burdens between
mice, the differences between the bmt1Δ mutant and the refer-
ence strain were signiﬁcant in the liver. Restoration of the native
BMT1 gene into bmt1Δ mutant attenuated signiﬁcantly its dis-
semination. The differences between the bmt1Δ bmt2Δ bmt5Δ
mutant and the wild-type strain were signiﬁcant in the different
organs analyzed.
The lectin, galectin-3 (Gal3), has been described as a β-Mans
receptor [35], and it is proposed to induce killing of C. albicans
[36]. Spleen, kidneys, and liver fungal burdens in Gal3−/− mice
Figure 4. Mapping of β-1,2-oligomannosides epitopes expressed at the
surface of hyphae. Indirect immunoﬂuorescence assays were performed on
hyphae from bmt1Δ, bmt1Δ/BMT1, bmt1Δ bmt2Δ bmt5Δ, and mnt1Δ
mnt2Δ mutants and their reference strain, CAI-4, using anti-β-1,2-oligo-
mannosides monoclonal antibody (mAb) 5B2 and lectin concanavalin A
(ConA). Evan’s blue was used as counterstain to decrease the nonspeciﬁc
background ﬂuorescence and to visualize nonstained cells, which display
then red ﬂuorescence in their cytoplasm (bmt1Δ/bmt2Δ/bmt5Δ mutant
with mAb 5B2). For each strain, a micrograph of phase contrast and a ﬂuo-
rescence micrograph with the mentioned antibody or lectin are shown.
Scale bars = 10 µm. All of the mutants and their reference strains are
Ura+ with CIp10 integrated in the same RPS1 allele.
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and C57BL/6 control mice were therefore analyzed following
intraperitoneal infection with the bmt1Δ and bmt1Δ bmt2Δ
bmt5Δ mutants and the control strain. The 2 mutants had the
tendency to disseminate less than the wild-type strain in liver of
C57BL/6 mice, but the difference was not signiﬁcant (Fig-
ure 5C). However, dissemination in the spleen and the kidneys
was similar for the 3 strains. It is interesting to note that spleen
from Gal3−/− mice infected with CAI-4 contained signiﬁcantly
higher fungal burdens than those from C57BL/6 mice (P < .05)
(Figure 5C and D). In contrast, no signiﬁcant difference was ob-
served with the 2 bmtsΔ mutants. Gal3−/− mice displayed lower
fungal burdens in the spleen when infected with the bmt1Δ/
bmt2Δ/bmt5Δ mutant (Figure 5D).
DISCUSSION
Surface mannoproteins have speciﬁc functions related to C. al-
bicans virulence including adhesion to host tissues, bioﬁlm
formation, and triggering of the immune system [37]. Some
of these virulence attributes are conferred through proteins
N- and/or O-glycans [14, 38]. Emphasis has then been placed
on the role of the cell wall glycans in the interplay between C.
albicans and its host. The commensal/pathogen transition is
critically dependent on the biological activities of speciﬁc
oligomannosides, including β-Mans that are recognized by
the soluble lectin Gal3 [35].These epitopes have immunomod-
ulatory properties [8, 11] and seem to be related to C. albicans
infections [10, 39]. Structural studies performed by Shibata
et al [4] have described β-Mans in PPM N-glycans, whereas
Trinel et al [5] characterized β-Mans in the PLM glycolipid,
a member of the mannose-inositol-phosphoceramide family.
We have later identiﬁed the 6 Bmts responsible for their bio-
synthesis [21, 22].
We have shown that β-Mans epitopes are widely distributed
among the different CWMPs [16]. We also demonstrated that,
in contrast to PPM, O-mannosylation is part of the C. albicans
β-1,2-mannosylation process. We report here the presence of
β-Mans and their biosynthetic process inC. albicans O-mannan.
Two mutants, bmt1Δ and bmt3Δ, had truncated O-mannosides
with an accumulation of O-mannotriose and O-mannotetraose,
respectively. Alpha-mannosidase treatment of O-mannosides
from wild-type strain digests all mannosides containing less
than 4 mannose residues, showing that a heteropolymer rath-
er than a homopolymer made up α-mannosidase-resistant
O-mannans. The Bmt1 is known to add β-mannose on α-1,2-
Mans in N-mannan, initiating then a heteropolymer composed
of α-1,2-Man with terminal β-Mans (Figure 1A) [21]. This
Bmt1 substrate would also be available on O-mannosides after
Figure 5. Virulence assays are shown. (A) Cumulative mortality of mice given injections of 4 × 105 cells from bmt1Δ, bmt1Δ/BMT1, and bmt1Δ bmt2Δ
bmt5Δ mutants and their reference strain, CAI-4. Difference between CAI-4 and bmt1Δ or bmt1Δ bmt2Δ bmt5Δ mutants were signiﬁcant (P < .05). Fungal
burdens of different Candida albicans strains in the spleen, kidney, and liver of BALB/c (B), C57BL/6 (C), and Gal3−/− (D) mice, 3 days postintraperitoneal
infection. Mice received intraperitoneal injection of 5 × 107 CAI-4, bmt1Δ, and bmt1Δ bmt2Δ bmt5Δ cells. The results shown are from 3 independent
experiments. *, P < .05; **, P < .01. All the mutants and their reference strains are Ura+ with CIp10 integrated in the same RPS1 allele.
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Mnt1 and possibly Mnt2 activities (Figure 3D) [14, 24]. The
mutant that lacks these 2 enzymes was deprived of β-mannosy-
lated O-mannopentaose and expressed less β-Mans on CWMPs
than the reference strain. As for β-Mans at the nonreducing end
of PPM α-1,2-Mans [21], Bmt3 adds the second β-mannose.
We highlighted heterogeneity of O-mannosides released from
yeast cells, and we demonstrated variability in the β-Mans con-
tent determined by growth temperature. The β-Mans expression
is complex because yeasts grown at 37°C express less β-Mans on
N-mannans than yeasts grown at 28°C [40, 41]. C. albicans cells
display 2 O-mannopentaoses (Man5) mainly composed of an
α-mannosidase-sensitive Man5 at 37°C and an α-mannosidase-
resistant Man5 at 28°C. These data suggest that β-Mans from
bothN- andO-mannans undergo the same temperature-dependent
regulation.
β-1,2-oligomannosides at the nonreducing end of α-1,2-Mans
are major CWMPs β-Mans in both yeasts and hyphae. Yeast
CWMPs from bmt1Δ mutant did not harbor β-Mans epitopes,
and 2 puriﬁed hyphal proteins, Hwp1 and Pra1, were no more
β-1,2-mannosylated when expressed in this mutant. Lack of
Bmt1 activity has been reported to have no impact on yeast sur-
face expression of β-Mans [21], certainly due to expression of al-
ternative sources of β-Mans such as those present on PLM and
N-mannans phosphomannosides. We were surprised to ﬁnd
that surface expression of β-Mans on germ tubes was initiated
only by Bmt1. β-1,2-mannosylation of Hwp1 and Pra1 was not
affected in the bmt2Δmutant (data not shown), but it was dimin-
ished in themnt1Δ/mnt2Δmutant, suggesting that hyphae-speciﬁc
N-mannans contain β-Mans only at the nonreducing end of
α-1,2-Mans. Supporting this hint, others have observed presence
of non-β-1,2-mannosylated phosphomannose in hyphae [42].
Surface cell wall molecules are important because they can di-
rectly interact with the host. However, β-Mans biosynthesized
by Bmt1 apparently have no detrimental impact on the host, be-
cause mutants lacking Bmt1 were more or equally virulent than
control strains in 2 different genetic background mice, BALB/c
and C57/BL6 mice, respectively. Wild-type strain clearly dis-
seminated more in organs of C57BL/6 mice, whereas differences
between mutants were lower between the 2 genetic background
mice. BALB/c and C57BL/6 mice can produce different immu-
nological responses to C. albicans infections that can impact
yeast virulence and dissemination [43, 44]. Likewise, male and
female mice might display different immune responses [45]. We
then used only female mice in this study. Putative sex-associated
differences in the regulation of β-Mans-dependent C. albicans
virulence should be analyzed in upcoming studies.
Our data strongly suggest that Bmt1-speciﬁc β-Mans are a
potential avirulence factor, whose presence attenuates patho-
gen-mediated damage. As revealed by ConA staining, deletion
of Bmt1 unmasks α-1,2-Mans, which are virulence attributes of
C. albicans [46]. We ruled out that remaining β-Mans in PPM
and PLM phosphomannosides of bmt1Δ mutant have the
potential to impact a more virulent phenotype by generating
bmt1Δ/bmt2Δ/bmt5Δ mutant. This strain, which contains no
β-Mans, had an equivalent virulence to the bmt1Δ mutant.
C. albicans yeast cell wall extracts were reported to induce mu-
rine vasculitis, which is associated with inﬂammatory response
that is increased in the absence of β-Mans [47]. Decrease surface
expression of β-Mans at 37°C can be considered as a mecha-
nism favoring exposure of α-1,2-Mans and then the transition
from commensal to pathogen.
Kohatsu et al [35, 36]have shown that Gal3, which is a soluble
lectin reported to bind β-Mans, could induce death of C. albicans
strains expressing β-Mans of the PPM acid stable and labile frac-
tions. Recent studies have demonstrated that this lectin helps
mice to overcome Candida systemic infections [48]. Galectin-3
may be secreted by neutrophils to aid opsonization and phagocy-
tosis of yeast cells [49]. However, incubation of bmt1Δ and
bmt1Δ/bmt2Δ/bmt5Δ mutants and their reference strain with
human neutrophils did not conﬁrm this hypothesis, and these
mutants were found to be more susceptible to these phagocytes
(data not shown). Comparing dissemination in C57BL/6 and
Gal3−/− mice, we showed that the wild-type strain was more vir-
ulent in the knockout mice, whereas the mutants had similar
(bmt1Δmutant) or reduced (bmt1Δ/bmt2Δ/bmt5Δmutant) vir-
ulence. These data indicate that Gal3 potentiates the elimination
of C. albicans; however, in Gal3−/− deﬁcient cells, β-Mans ex-
pressing strains of C. albicans are more virulent.
CONCLUSIONS
Our data show that β-Mans expression is under the control of
regulatory mechanisms that favor exposure of α-1,2-Mans and
their associated virulence and facilitate the yeast to counteract
Gal3-mediated host defenses. Regulation of Gal3 expression by
the host and regulation of β-Mans expression by C. albicans
may be crucial events controlling the balance between sapro-
phytic and parasitic status of the yeast.
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